|
Apr 4
|
Pharming Group announces the 2024 Annual General Meeting of Shareholders
|
|
Apr 4
|
Pharming Group announces the filing of its 2023 Annual Report and Form 20-F
|
|
Apr 3
|
Pharming Group to participate in April investor conferences
|
|
Feb 29
|
Pharming Group to report fourth quarter and full year 2023 financial results on March 14
|
|
Aug 9
|
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
|